- Moderna CEO Stéphane Bancel gave an interview to The Wall Street Journal.
Moderna CEO Stéphane Bancel said investors misread the cancer vaccine data, comparing its benefit to Keytruda's early days. He outlined plans for pharmacy-based administration and a preventive vaccine for Lynch syndrome, but risks include a 17% screening failure rate and secrecy around the proprietary software.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.